129 related articles for article (PubMed ID: 38885312)
1. Single-stranded DNA Gap Accumulation is a Functional Biomarker for USP1 Inhibitor Sensitivity.
da Costa AABA; Somuncu O; Ravindranathan R; Mukkavalli S; Martignetti DB; Nguyen H; Jiao Y; Lamarre BP; Sadatrezaei G; Moreau L; Liu J; Iyer DR; Lazaro JB; Shapiro GI; Parmar K; D'Andrea AD
Cancer Res; 2024 Jun; ():. PubMed ID: 38885312
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.
Simoneau A; Engel JL; Bandi M; Lazarides K; Liu S; Meier SR; Choi AH; Zhang H; Shen B; Martires L; Gotur D; Pham TV; Li F; Gu L; Gong S; Zhang M; Wilker E; Pan X; Whittington DA; Throner S; Maxwell JP; Chen Y; Yu Y; Huang A; Andersen JN; Feng T
Mol Cancer Ther; 2023 Feb; 22(2):215-226. PubMed ID: 36228090
[TBL] [Abstract][Full Text] [Related]
3. USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors.
Lim KS; Li H; Roberts EA; Gaudiano EF; Clairmont C; Sambel LA; Ponnienselvan K; Liu JC; Yang C; Kozono D; Parmar K; Yusufzai T; Zheng N; D'Andrea AD
Mol Cell; 2018 Dec; 72(6):925-941.e4. PubMed ID: 30576655
[TBL] [Abstract][Full Text] [Related]
4. POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells.
Belan O; Sebald M; Adamowicz M; Anand R; Vancevska A; Neves J; Grinkevich V; Hewitt G; Segura-Bayona S; Bellelli R; Robinson HMR; Higgins GS; Smith GCM; West SC; Rueda DS; Boulton SJ
Mol Cell; 2022 Dec; 82(24):4664-4680.e9. PubMed ID: 36455556
[TBL] [Abstract][Full Text] [Related]
5. USP1-dependent nucleolytic expansion of PRIMPOL-generated nascent DNA strand discontinuities during replication stress.
Nusawardhana A; Pale LM; Nicolae CM; Moldovan GL
Nucleic Acids Res; 2024 Mar; 52(5):2340-2354. PubMed ID: 38180818
[TBL] [Abstract][Full Text] [Related]
6. Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps.
Paes Dias M; Tripathi V; van der Heijden I; Cong K; Manolika EM; Bhin J; Gogola E; Galanos P; Annunziato S; Lieftink C; Andújar-Sánchez M; Chakrabarty S; Smith GCM; van de Ven M; Beijersbergen RL; Bartkova J; Rottenberg S; Cantor S; Bartek J; Ray Chaudhuri A; Jonkers J
Mol Cell; 2021 Nov; 81(22):4692-4708.e9. PubMed ID: 34555355
[TBL] [Abstract][Full Text] [Related]
7. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
Taglialatela A; Leuzzi G; Sannino V; Cuella-Martin R; Huang JW; Wu-Baer F; Baer R; Costanzo V; Ciccia A
Mol Cell; 2021 Oct; 81(19):4008-4025.e7. PubMed ID: 34508659
[TBL] [Abstract][Full Text] [Related]
8. EXO1 and DNA2-mediated ssDNA gap expansion is essential for ATR activation and to maintain viability in BRCA1-deficient cells.
García-Rodríguez N; Domínguez-García I; Domínguez-Pérez MDC; Huertas P
Nucleic Acids Res; 2024 Jun; 52(11):6376-6391. PubMed ID: 38721777
[TBL] [Abstract][Full Text] [Related]
9. ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms.
Leung W; Simoneau A; Saxena S; Jackson J; Patel PS; Limbu M; Vindigni A; Zou L
Cell Rep; 2023 Jul; 42(7):112792. PubMed ID: 37454295
[TBL] [Abstract][Full Text] [Related]
10. Schlafen 11 further sensitizes BRCA-deficient cells to PARP inhibitors through single-strand DNA gap accumulation behind replication forks.
Onji H; Tate S; Sakaue T; Fujiwara K; Nakano S; Kawaida M; Onishi N; Matsumoto T; Yamagami W; Sugiyama T; Higashiyama S; Pommier Y; Kobayashi Y; Murai J
Oncogene; 2024 Jul; ():. PubMed ID: 38961202
[TBL] [Abstract][Full Text] [Related]
11. Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells.
Tirman S; Quinet A; Wood M; Meroni A; Cybulla E; Jackson J; Pegoraro S; Simoneau A; Zou L; Vindigni A
Mol Cell; 2021 Oct; 81(19):4026-4040.e8. PubMed ID: 34624216
[TBL] [Abstract][Full Text] [Related]
12. POLθ processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells.
Schrempf A; Bernardo S; Arasa Verge EA; Ramirez Otero MA; Wilson J; Kirchhofer D; Timelthaler G; Ambros AM; Kaya A; Wieder M; Ecker GF; Winter GE; Costanzo V; Loizou JI
Cell Rep; 2022 Nov; 41(9):111716. PubMed ID: 36400033
[TBL] [Abstract][Full Text] [Related]
13. Filling in the gaps in PARP inhibitor-induced synthetic lethality.
Paes Dias M; Jonkers J
Mol Cell Oncol; 2021; 8(6):2010512. PubMed ID: 35419484
[TBL] [Abstract][Full Text] [Related]
14. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
Cong K; Peng M; Kousholt AN; Lee WTC; Lee S; Nayak S; Krais J; VanderVere-Carozza PS; Pawelczak KS; Calvo J; Panzarino NJ; Turchi JJ; Johnson N; Jonkers J; Rothenberg E; Cantor SB
Mol Cell; 2021 Aug; 81(15):3128-3144.e7. PubMed ID: 34216544
[TBL] [Abstract][Full Text] [Related]
15. The
Simoneau A; Xiong R; Zou L
Genes Dev; 2021 Sep; 35(17-18):1271-1289. PubMed ID: 34385259
[TBL] [Abstract][Full Text] [Related]
16. The USP1/UAF1 complex promotes double-strand break repair through homologous recombination.
Murai J; Yang K; Dejsuphong D; Hirota K; Takeda S; D'Andrea AD
Mol Cell Biol; 2011 Jun; 31(12):2462-9. PubMed ID: 21482670
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.
Tyagi A; Kaushal K; Chandrasekaran AP; Sarodaya N; Das S; Park CH; Hong SH; Kim KS; Ramakrishna S
Theranostics; 2022; 12(13):5949-5970. PubMed ID: 35966591
[No Abstract] [Full Text] [Related]
18. CRISPR knockout genome-wide screens identify the HELQ-RAD52 axis in regulating the repair of cisplatin-induced single stranded DNA gaps.
Pale LM; Khatib JB; Nicolae CM; Moldovan GL
bioRxiv; 2024 Apr; ():. PubMed ID: 38659927
[TBL] [Abstract][Full Text] [Related]
19. Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen.
Hedglin M; Aitha M; Pedley A; Benkovic SJ
J Biol Chem; 2019 Mar; 294(13):5157-5168. PubMed ID: 30700555
[TBL] [Abstract][Full Text] [Related]
20. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness.
Gralewska P; Gajek A; Marczak A; Mikuła M; Ostrowski J; Śliwińska A; Rogalska A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
